Cite
JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia.
MLA
Kaeda, Jaspal, et al. “JAK2 V617F Allele Burden Quantified by Real Time Quantitative Polymerase Chain Reaction and Competitive Polymerase Chain Reaction in Patients with Chronic Myeloproliferative Neoplasia.” Leukemia & Lymphoma, vol. 55, no. 1, Jan. 2014, pp. 128–35. EBSCOhost, https://doi.org/10.3109/10428194.2013.797085.
APA
Kaeda, J., Bonamino, M., Ayres-Silva, J., Solza, C., Ringel, F., Blau, O., Daumas, A., Oberender, C., Dörken, B., le Coutre, P., & Zalcberg, I. (2014). JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia. Leukemia & Lymphoma, 55(1), 128–135. https://doi.org/10.3109/10428194.2013.797085
Chicago
Kaeda, Jaspal, Martin Bonamino, Jackline Ayres-Silva, Cristiana Solza, Frauke Ringel, Olga Blau, Ademo Daumas, et al. 2014. “JAK2 V617F Allele Burden Quantified by Real Time Quantitative Polymerase Chain Reaction and Competitive Polymerase Chain Reaction in Patients with Chronic Myeloproliferative Neoplasia.” Leukemia & Lymphoma 55 (1): 128–35. doi:10.3109/10428194.2013.797085.